Publications by authors named "Andrea Caenazzo"
J Clin Oncol
February 2004
Article Synopsis
- - The study examined the safety and effectiveness of low-dose thalidomide in patients with advanced myelofibrosis, starting treatment at 50 mg and potentially increasing to 400 mg based on tolerance.
- - Out of 63 patients, about half managed to take over 100 mg daily, but the dropout rate at 6 months was 51%, with lower dropouts in those reporting higher fatigue levels.
- - Results showed benefits like improved anemia (22%), reduced need for transfusions (39%), increased platelet counts in 22% of certain patients, and significant reductions in disease severity and fatigue in 31% of participants.
